ROLE AND REGULATION OF CDK4 IN THE NORMAL LENS
ROLE AND REGULATION OF CDK4 IN THE NORMAL LENS
批准号:
2906760
负责人:
RONALD ANTHONY DEPINHO
金额:
$32.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-01-26 至 2000-12-31
关键词:
cell cycle cell differentiation cell growth regulation cyclin dependent kinase cyclins developmental genetics enzyme activity gene expression gene mutation genetically modified animals growth factor immunocytochemistry in situ hybridization laboratory mouse laboratory rat lens neoplastic transformation phenotype phosphorylation protein structure function protooncogene retinoblastoma protein tumor suppressor genes western blottings
中文摘要
阐明控制细胞生长的分子机制是
对于我们对正常发育和癌症的理解至关重要。的目标是
这项建议是为了探索对主细胞周期的调节
检查点,G1/S的过渡,在开发中的鼠标的上下文中
镜头。我们的主要关注点将放在对依赖于细胞周期蛋白G1的调控上
CDK、CDK4及其与视网膜母细胞瘤的功能关系
(Rb)蛋白质。CDK4复合体占据了细胞周期的中心阶段
领域,因为它在增殖反应中的重要文献记载的重要性
细胞对生长因子及其相关蛋白的参与
在癌症发病机制中的作用。CDK4复合体的活性在很大程度上受到调节
部分通过与正性(细胞周期蛋白D)和负性的直接相互作用
(CDK4的抑制剂,例如p15/INK4和p16INK4)调节蛋白。欠款
在过去的6年里奠定了基础,我的实验室现在是独一无二的
定位为全面解决CDK4的功能和
它在哺乳动物正常发育过程中的相关调节蛋白。这
机会来自(一)将镜片建立为理想的系统
用于检查体内的生长控制(EMBO J,1995)并证明
Rb是CDK4的底物,在晶状体细胞中起着核心和重要的作用
生长控制(自然,1994),(Ii)功能性
几种细胞中p16INK4、CDK4、Myc和Rb蛋白的相互关系
培养系统(科学,1995),(Iii)4种不同转基因的产生
小鼠品系(各种细胞周期蛋白D和CDK4结构)和生殖系Null
Pl6INK4基因的突变,(Iv)易癌转基因的可用性
我们和其他人创造的小鼠模型,最重要的是,(V)
使用鼠标作为实验系统的丰富经验
基因功能分析。对这一完整补充性的描述
功能增强和功能丧失的鼠标模型将使我们能够
了解细胞周期蛋白D、CDK4和p15INK4、p16INK4基因在
G1期/S期细胞周期在正常组织中的调节
癌症的起源。关于癌症研究,我们将审查和
比较每种小鼠模型中肿瘤的发生和分布
单独地,相互结合,或与癌症结合-
容易感染的小鼠(例如P53-/-或我们的一些Myc转基因基因)。最后,
P16INK4与家族性黑色素瘤的联系将促使对
P16INK裸鼠紫外线照射是否加速皮肤发育
癌症。
英文摘要
Elucidation of the molecular mechanisms governing cellular growth is
central to our understanding of normal development and cancer. The goal of
this proposal is to explore the regulation of the principal cell cycle
checkpoint, the G1/S transition, in the context of the developing mouse
lens. Our main focus will be on the regulation of a G1 cyclin-dependent
kinase (cdk), cdk4, and its functional relationship to the retinoblastoma
(Rb) protein. The cdk4 complex has captured center stage in the cell cycle
field because of its documented importance in the proliferative response of
cells to growth factors and of the involvement of its associated proteins
in cancer pathogenesis. Activity of the cdk4 complex is regulated in large
part through direct interactions with positive (cyclin D) and negative
(inhibitors of cdk4, e.g. p15/INK4 and p16INK4) modulatory proteins. Owing
to a foundation laid over the past 6 years, my laboratory is now uniquely
positioned to address in a comprehensive manner the function of cdk4 and
its associated regulatory proteins in normal mammalian development. This
opportunity arises from (i) establishment of the lens as an ideal system
for examining growth control in vivo (EMBO J, 1995) and demonstration that
Rb, the substrate of cdk4, plays a central and essential role in lens cell
growth control (Nature, 1994), (ii) characterization of the functional
interrelationships among p16INK4, cdk4, Myc and Rb proteins in several cell
culture systems (Science, 1995), (iii) generation of 4 different transgenic
mouse lines (various cyclin D and cdk4 constructs) and a germline null
mutation of the pl6INK4 gene, (iv) availability of cancer-prone transgenic
mouse models that we and others have generated, and most importantly, (v)
extensive experience in employing the mouse as an experimental system for
the analysis of gene function. Characterization of this full complement of
gain-of function and loss-of-function mouse models will allow us to
understand the function of cyclin D, cdk4, and p15INK4, p16INK4 genes in
the regulation of the G1/S transition in normal tissues in vivo and in the
genesis of cancer. With respect to the cancer studies, we will examine and
compare the onset and distribution of tumors arising in each mouse model
separately, in combination with each other, or in conjunction with cancer-
prone mice (such as p53-/- or some of our Myc transgenics). Finally, the
connection of p16INK4 to familial melanoma will prompt an assessment of
whether UV exposure of null p16INK mice accelerates the development of skin
cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying and targeting collateral lethal vulnerabilities in cancers
-
批准号:10563469
-
项目类别:
-
资助金额:$96.7万
-
财政年份:2023
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Exploring Collateral Lethality for Development of Cancer Therapeutics
-
批准号:10365970
-
项目类别:
-
资助金额:$46.43万
-
财政年份:2018
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Metastatic Colorectal Cancer
-
批准号:9768989
-
项目类别:
-
资助金额:$35.38万
-
财政年份:2018
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Exploring Collateral Lethality for Development of Cancer Therapeutics
-
批准号:9899100
-
项目类别:
-
资助金额:$47.41万
-
财政年份:2018
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Metastatic Colorectal Cancer
-
批准号:10229510
-
项目类别:
-
资助金额:$36.48万
-
财政年份:2018
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Metastatic Colorectal Cancer
-
批准号:10474624
-
项目类别:
-
资助金额:$38.18万
-
财政年份:2018
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Cancer Clinical Investigator Team Leadership Award
-
批准号:8759976
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2013
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Cancer Center Support Grant - CTRP Supplement
-
批准号:8759942
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2013
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Program Leaders of Research Programs
-
批准号:8759762
-
项目类别:
-
资助金额:$57.04万
-
财政年份:2013
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetic Engineering Mouse Core
-
批准号:8052127
-
项目类别:
-
资助金额:$8.38万
-
财政年份:2011
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
FUNCTIONAL GENOMIC IDENTIFICATION AND CHARACTERIZATION OF THERAPEUTIC TARGETS
-
批准号:8052103
-
项目类别:
-
资助金额:$31.95万
-
财政年份:2011
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
ADMINISTRATION CORE
-
批准号:8052128
-
项目类别:
-
资助金额:$3.43万
-
财政年份:2011
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
The role of FOXO transcriptional factors in TSC-mediated tumorigenesis
-
批准号:7679614
-
项目类别:
-
资助金额:$20.52万
-
财政年份:2008
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
The role of FOXO transcriptional factors in TSC-mediated tumorigenesis
-
批准号:7511002
-
项目类别:
-
资助金额:$17.1万
-
财政年份:2008
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Project 1: Targeting Metabolic Dependencies in PDAC
-
批准号:9074440
-
项目类别:
-
资助金额:$57.52万
-
财政年份:2006
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Pancreatic Duct Adenocarcinoma
-
批准号:7591831
-
项目类别:
-
资助金额:$183.84万
-
财政年份:2006
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
-
批准号:8019210
-
项目类别:
-
资助金额:$201.96万
-
财政年份:2006
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
-
批准号:8603762
-
项目类别:
-
资助金额:$205.71万
-
财政年份:2006
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Pancreatic Duct Adenocarcinoma
-
批准号:7223402
-
项目类别:
-
资助金额:$177.09万
-
财政年份:2006
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
Genetics and Biology of Pancreatic Duct Adenocarcinoma
-
批准号:7754684
-
项目类别:
-
资助金额:$189.92万
-
财政年份:2006
-
负责人:RONALD ANTHONY DEPINHO
-
依托单位:
海外基金